Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):788-793. doi: 10.1089/AID.2018.0297. Epub 2019 Jun 19.

PMID:
31119944
2.

Brief Report: Cocaine Use and Pre-exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function.

Hojilla JC, Satre DD, Glidden DV, McMahan VM, Gandhi M, Defechereux P, Guanira JV, Mehrotra M, Grant RM, Carrico AW.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):78-82. doi: 10.1097/QAI.0000000000001972.

PMID:
30730359
3.

Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project.

Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Okochi H, Kuncze K, Mehrotra M, Defechereux P, Buchbinder SP, Grant RM, Gandhi M.

AIDS. 2019 Apr 1;33(5):867-872. doi: 10.1097/QAD.0000000000002135.

PMID:
30649051
4.

Identification of hepatitis B virus genotype I in Thailand.

Holzmayer V, Hance R, Defechereux P, Grant R, Kuhns MC, Cloherty G, Rodgers MA.

J Med Virol. 2019 Apr;91(4):717-721. doi: 10.1002/jmv.25346. Epub 2018 Nov 8.

5.

Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.

Jotwani V, Scherzer R, Glidden DV, Mehrotra M, Defechereux P, Liu A, Gandhi M, Bennett M, Coca SG, Parikh CR, Grant RM, Shlipak MG.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):169-174. doi: 10.1097/QAI.0000000000001654.

6.

The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men.

Mehrotra ML, Rivet Amico K, McMahan V, Glidden DV, Defechereux P, Guanira JV, Grant RM.

AIDS Behav. 2018 Nov;22(11):3673-3680. doi: 10.1007/s10461-018-2151-0.

7.

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.

Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham SW, Hammond P, Margolis D, Murray M.

AIDS Behav. 2018 Nov;22(11):3540-3549. doi: 10.1007/s10461-017-2017-x.

8.

The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study.

Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, Mayer KH, Veloso VG, Bekker LG, Avelino-Silva VI, Schechter M, Grant RM.

AIDS Behav. 2016 Jul;20(7):1527-34. doi: 10.1007/s10461-016-1415-9.

9.

Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.

Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF.

J Infect Dis. 2016 Feb 15;213(4):569-73. doi: 10.1093/infdis/jiv425. Epub 2015 Aug 26.

10.

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).

Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, Vargas L, Amico KR, Chodacki P, Fernandez T, Avelino-Silva VI, Burns D, Grant RM; iPrEx Study Team.

AIDS Behav. 2016 Jul;20(7):1478-88. doi: 10.1007/s10461-015-1082-2.

11.

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.

Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereux P, Guanira JV, Grinsztejn B, Chariyalertsak S, Bekker LG, Grant RM; iPrEx Study Team.

J Infect Dis. 2015 Nov 1;212(9):1402-6. doi: 10.1093/infdis/jiv239. Epub 2015 Apr 20.

12.

Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women.

Grant RM, Liegler T, Defechereux P, Kashuba AD, Taylor D, Abdel-Mohsen M, Deese J, Fransen K, De Baetselier I, Crucitti T, Bentley G, Agingu W, Ahmed K, Damme LV.

AIDS. 2015 Jan 28;29(3):331-7.

PMID:
25503265
13.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

14.

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.

Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M; IMPAACT P1057 Team.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):189-96. doi: 10.1097/QAI.0b013e3181e46308.

15.

Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T; Pediatric ACTG Cryopreservation Working Group.

Clin Vaccine Immunol. 2009 Aug;16(8):1176-86. doi: 10.1128/CVI.00342-08. Epub 2009 Jun 10.

16.

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team.

J Infect Dis. 2006 Jan 15;193(2):302-11. Epub 2005 Dec 7.

PMID:
16362896
19.

Overview of the replication cycle of varicella-zoster virus.

Sadzot-Delvaux C, Baudoux L, Defechereux P, Piette J, Rentier B.

Contrib Microbiol. 1999;3:21-42. Review. No abstract available.

PMID:
10599519
20.
21.

Lessons to be learned from varicella-zoster virus.

Rentier B, Piette J, Baudoux L, Debrus S, Defechereux P, Merville MP, Sadzot-Delvaux C, Schoonbroodt S.

Vet Microbiol. 1996 Nov;53(1-2):55-66. Review.

22.

Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins.

Schoonbroodt S, Piette J, Baudoux L, Defechereux P, Rentier B, Merville MP.

J Med Virol. 1996 Aug;49(4):264-73.

PMID:
8877757
23.

Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein.

Defechereux P, Debrus S, Baudoux L, Schoonbroodt S, Merville MP, Rentier B, Piette J.

J Gen Virol. 1996 Jul;77 ( Pt 7):1505-13.

24.

Varicella-zoster virus gene regulation.

Piette J, Defechereux P, Baudoux L, Debrus S, Merville MP, Rentier B.

Neurology. 1995 Dec;45(12 Suppl 8):S23-7. Review.

PMID:
8545012
25.

Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Baudoux L, Defechereux P, Schoonbroodt S, Merville MP, Rentier B, Piette J.

Nucleic Acids Res. 1995 Apr 25;23(8):1341-9.

26.

Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.

Kinchington PR, Vergnes JP, Defechereux P, Piette J, Turse SE.

J Virol. 1994 Jun;68(6):3570-81.

27.

Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product.

Defechereux P, Melen L, Baudoux L, Merville-Louis MP, Rentier B, Piette J.

J Virol. 1993 Jul;67(7):4379-85.

28.

Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein.

Jackers P, Defechereux P, Baudoux L, Lambert C, Massaer M, Merville-Louis MP, Rentier B, Piette J.

J Virol. 1992 Jun;66(6):3899-903.

Supplemental Content

Loading ...
Support Center